BioAge Labs, Inc. Common Stock
$8.06
-$0.03 (-0.37%)
$7.86Day Range$8.23
Key Statistics
Market Cap
$369.93M
Shares Outstanding
45.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 26, 2024
Round Lot
100
Locale
US
Trading Data
Day Open
$8.07
Day High
$8.23
Day Low
$7.86
Volume
1.51M
VWAP
$8.04
Prev Close
$8.09
Transactions
--
Acc. Volume
--
About BioAge Labs, Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
PHARMACEUTICAL PREPARATIONSSIC 283462 employees5885 HOLLIS STREET, EMERYVILLE, CA, 94608510-806-1445IPO Sep 26, 2024US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001709941
- Composite FIGI
- BBG00HBTB0M9
- Share Class FIGI
- BBG00HBTB0N8
- Ticker Root
- BIOA
- SIC Code
- 2834
About BioAge Labs, Inc. Common Stock (BIOA) Stock
BioAge Labs, Inc. Common Stock (BIOA) closed the 2026-09-18 session at $8.06, down 0.37% versus the previous close (-0.03). The stock opened at $8.07 and traded between $7.86 and $8.23 during that session. Session trading volume was 1.5M shares. The volume-weighted average price (VWAP) is $8.04.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
BioAge Labs, Inc. Common Stock has a market capitalization of $369.9 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. BIOA is listed on the XNAS exchange. The company employs approximately 62 people. BioAge Labs, Inc. Common Stock is headquartered in EMERYVILLE, CA. The recorded listing date is 2024-09-26.
On this page you can find market BIOA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.